The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Anyone been following the odx, avct boards?
I'd happily take a small rise per week to stay under the radar and keep that shower of gobsights away.
Someone has took an interest in it, spent 100k just before the bell. It makes me more comfortable with my holdings when these big buys come in.
Will be on sharesmagazine.co.uk. In a couple of days they said at the start of the presentation.
I couldn't join the call but Ali seems to have been hinting at big things on the horizon for a while. Mind you it needs to materialise because a £100m market cap has to be justified with revenues and deals and they have been thin on the ground in the past 6 months..!
It's like asking a geologist where the best place to find gold is and going 50 50. He shows you the best place to look and you do all the digging. One day there's going to be big returns.
I do think Etx has something very valuable here and I was very impressed in the way Ali tried to explain how it all works
. I have a better if limited knowledge of this company assets now.
*lots of positive hints.
Re the lsit of present collaborations - that has remained static. Do we need to see some more tangible commercial interest to get the SP motoring?
The 100mil deals are clearly an aim for Ali.
That was fun - unlucky with the Middle Slot and a bit rushed at the end. Only 3 questions.
As regards future plans/directions - against of positive hints, no negative body language, and a feeling of confidence bordering on smugness in how things can develop.
Interested in others opinions, sorry this is rushed. Always feel much better in this long term hold and add for me after these presentations.
Yeah I've registered. I'm hoping we might get an rns before Wednesday close, there's plenty to update on and potentially big news.
Fingers crossed.
Link to webinar on 17/02. https://register.gotowebinar.com/register/2576067096002265100
Looking forward to the Webinar.
The same as that.
Keep an eye out for how often 'mRNA' gets mentioned in social media during the year.
Ha did cross my mind but no one really looks at this board just us. I'm going to try and increase over next few weeks if possible. If just they pull this off, this will be in the ££s. Just on this alone.
Shhhhush, Icey.
Load up first then throw a firecracker in amongst the herd.
Also...
We have uncovered new mechanisms that mitigate infection-induced hyperinflammation as well discovering a potent anti-viral strategy. Our findings have highlighted Bardoxolone Methyl which is already the subject of an investigator led COVID-19 trial (NCT04494646).
The surprise finding of this compound's anti-viral activity alongside its well observed anti-inflammatory properties has led us to file a patent (GB2017631.9) which describes the use of Bardoxolone and related compounds to treat Covid-19 and other viral diseases. Previous knowledge of similar compounds has focused on the activation of the NRF2 pathway. Here, we show that both the anti-viral and anti-inflammatory properties we have observed depend on GRP94. We demonstrate that other selective GRP94 inhibitors may also be active anti-virals against a range of coronaviruses. Should Bardoxolone Methyl be progressed from its Phase 2 safety evaluation in NCT04494646 into Phase 3, we would be happy to share our anti-viral analysis with the sponsor.
To date, no compounds with this type of potent dual activity have been reported and clinical approaches have focused on combination drug therapies using anti-inflammatory compounds such as dexamethasone combined with anti-virals such as Remdesivir. Irrespective of our findings for Bardoxolone, we believe that our project will open deeper interest in selective GRP94 inhibitors and GRP94 as a possible target for future development of therapeutics not only for COVID
Re reading the rns a couple of times today and I think this has been vastly overlooked, especially by investors like myself. Take another look and see what you think to this part of it.
In May 2020, small molecule compounds predicted by our platform were tested in validated SARS-CoV-2 in vitro assays at WuXi AppTech. These compounds showed potent anti-inflammatory and anti-viral activity. We report here that in vitro assays have confirmed our in silico predictions and we have identified a clear mechanism, target and clinical stage compounds. These compounds are active against GRP94 and have anti-inflammatory and anti-viral activity against Sars-CoV-2. This activity generalises to other alpha and beta coronaviruses and is expected to be generically applicable, raising the prospect of utility against both existing coronaviruses that cause serious disease such as SARS and MERS and against new emergent strains of coronavirus.
The clinical stage compounds identified have been developed in humans for alternative indications and have an established safety profile in man. These, and other selective compounds sharing this target, could be rapidly deployed into clinical trials to treat patients with serious Covid-19 disease. Given our mechanistic insights, it would also be feasible to develop novel, highly selective drugs against GRP94. We continue to work on repurposable combinations using our platform and have compound combinations currently in testing. We anticipate data that will enhance our understanding further in Q1 2021.
Thanks for that, got myself registered.
There's alot of potential news flow over the next few months, will be interesting to hear this presentation.
https://shareprices.com/news/e-therapeutics-will-be-presenting-via-the-shares-and-aj-bell-investor-evening-webinar-on-17-february-2021-at-1800-gmt-w6q32d41y1113kx
Free to register for webinar.
Well the cars on hold, just took profits out of gdr and added another 10k worth here. The daily volume seems to be steadily climbing, something is going to happen soon people are taking positions. Get yourself ready.
No worries, someone else must of watched it and thought the same. Look at those late trades as gkb has pointed out. Wowzer.
I'm hoping my gdr go through the roof then can plunge in here with a decent holdings.
Iseenoships - thanks for sharing the youtube link - https://youtu.be/YdEbY6qC6BU
Watched it at the weekend and really whetted the appetite - particularly where he talked about conceivably doing collaborations for £100m+. That would see the current MCAP many multiples of what it is currently!
Bit odd you have just bought in then your first post is to say, 'should I be concerned'.
Why did you buy in the first place?
Should I be concerned?
New information on this company as not many cover it. Hoping this will all change soon.
Sorry pressed post before I got to finish.
Haha nice.... He's going to be a very wealthy chap in the near future, money aswell as brains.
I will just have to do with my good looks.
You have to grab any bit of positive findings on this share as so hard to find
That was the closing valuation on Friday. I actually tweeted Ali to congratulate him and his response was very bullish..
https://twitter.com/holdmybeer13/status/1358476925858152449?s=21